A rapid molecular testing quality initiative to reduce targeted treatment delays in hospitalized patients with new advanced non-small cell lung cancer (aNSCLC).
Year: 2025
Type: conference-abstract
Source: JCO Oncology Practice
Institution: Northwell Health
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414893645
Cites:
Cited by:
Related to: